Archive | linkedin RSS feed for this section

6th Annual World Health Care Congress – Europe

The 6th Annual World Health Care Congress – Europe is taking place 19-20 May, 2010 in Brussels, Belgium. This annual event is the only major international forum that convenes over 400 leaders from all sectors of health care to share the best practices and successful initiatives for improved delivery and outcomes in Europe. The 2010 [...]

Read full storyComments { 0 }

Handicare Consolidates Position In The Accessibility Market – Growth Story Continues

Following on from the Freelift and Minivator Handicare acquisitions, the company has acquired 15 million NOK Norwegian company KWS Rehab AS. In addition to the obvious synergies this provides Handicare with additional access to the growing private market. More here:

Read full storyComments { 1 }

Thomas Rossnagel – Sunrise Medical – Premium Focus Plus Maximum Efficiency

Thomas Rossnagel has in his relatively short tenure at Sunrise as CEO (he was formally Sunrise European President) put his characteristic formula of higher value added, targeted product lines – together with maximum operational effectiveness in serving customers best – into practice. He is well known for having done this very effectively in Europe. Sunrise [...]

Read full storyComments { 0 }

EasyJet Sucks – Marie-Patricia Hoarau – 38 – In A Wheelchair Ejected From Flight

Marie-Patricia Hoarau, a wheelchair user, was ejected from an EasyJet flight from Paris to Nice in France because she did not have somebody travelling with her. EasyJet allegedly citing so called European regulations has said that they ejected her because of European regulations. Say what?? They had let her fly before with no issues. All [...]

Read full storyComments { 0 }

German Health Minister Philipp Roesler – To Slam Pharma – (Wheelchairs And Homecare Next)?

New German Health Minister Takes Aim At Traditional Pharma Companies. Newly appointed German Healthcare Minister Philipp Roesler – liberal – Free Democratic Party in likely move to break big pharma stronghold and submit new products to insurance pricing scrutiny and impose an “efficiency and clinical effectiveness /outcomes” pricing performance ratio. Not totally dissimilar to the [...]

Read full storyComments { 0 }